Cargando…
Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma
BACKGROUND: Osteosarcoma is the most common primary bone tumor. The survival rate of osteosarcoma patients has not significantly increased in the past decades. Uncovering the mechanisms of malignancy, progression, and metastasis will shed light on the development of new therapeutic targets and treat...
Autores principales: | Gong, Yubao, Wei, Zheng‐Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327663/ https://www.ncbi.nlm.nih.gov/pubmed/34383385 http://dx.doi.org/10.1002/cnr2.1522 |
Ejemplares similares
-
PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation
por: Li, Xiao, et al.
Publicado: (2023) -
26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy
por: Rubio, Andres J., et al.
Publicado: (2021) -
Targeting PSMD14 inhibits melanoma growth through SMAD3 stabilization
por: Yokoyama, Satoru, et al.
Publicado: (2020) -
The prognostic value of USP14 and PSMD14 expression in non-small cell lung cancer
por: Lei, Jian, et al.
Publicado: (2021) -
PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2
por: Cheng, Ya-Min, et al.
Publicado: (2018)